Should You Accumulate Cresco Labs Inc (CRLBF) in Drug Manufacturers

Cresco Labs Inc (CRLBF) is around the bottom of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. CRLBF received an overall rating of 23, which means that it scores higher than 23 percent of all stocks. Cresco Labs Inc also achieved a score of 23 in the Drug Manufacturers - Specialty & Generic industry, putting it above 23 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 114 out of the 148 industries.

CRLBF has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on CRLBF!

See Full CRLBF Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 23 means the stock is more attractive than 23 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cresco Labs Inc Stock Today?

Cresco Labs Inc (CRLBF) stock is trading at $1.13 as of 12:45 PM on Tuesday, Nov 7, a loss of -$0.01, or -0.88% from the previous closing price of $1.14. The stock has traded between $1.11 and $1.15 so far today. Volume today is light. So far 239,612 shares have traded compared to average volume of 700,031 shares. Click Here to get the full Stock Report for Cresco Labs Inc stock.